Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial
- Submitting institution
-
The University of Leeds
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- UOA3-1561
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(15)01167-8
- Title of journal
- The Lancet
- Article number
- -
- First page
- 1066
- Volume
- 387
- Issue
- 10023
- ISSN
- 0140-6736
- Open access status
- Out of scope for open access requirements
- Month of publication
- March
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
18
- Research group(s)
-
A - Nursing and Allied Health
- Citation count
- 135
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Contribution A: Contribution to the organisation of the conduct of the study,Contribution to carrying out the study
Contribution B: The author helped draft the output
- Non-English
- No
- English abstract
- -